Lilly CEO Talks Fighting Cancer and Obesity, Drug Pricing
Jan 13 2025
Length: 11 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Unfollow podcast failed

Lilly CEO Talks Fighting Cancer and Obesity, Drug Pricing

Listen for free

View show details

Summary
Eli Lilly Chief Executive Officer Dave Ricks talks about paying $2.5 billion for a cancer drug being developed by Scorpion Therapeutics. He also says Lilly's experimental weight-loss pill could be approved in early 2026. He speaks to Bloomberg's Katie Greifeld from the JPMorgan Healthcare Conference in San Francisco.
See omnystudio.com/listener for privacy information.

Show More Show Less

Only £0.99 a month for the first 3 months. Pay £0.99 for the first 3 months, and £7.99/month thereafter. Renews automatically. Terms apply. Start my membership

Show More Show Less

What listeners say about Lilly CEO Talks Fighting Cancer and Obesity, Drug Pricing

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon